# A Study to Evaluate the Safety, Tolerability and the Effects of Ixodes Ricinus-Contact Phase Inhibitor (Ir-CPI) in Adult Patients With Spontaneous Intracerebral Haemorrhage

> clinical trial · VERIFIED · 2026-07-23

Status: COMPLETED · Sponsor: Bioxodes S.A. · Condition: Intracerebral Hemorrhage

- Company: Bioxodes S.A.
- Sector: Intracerebral Hemorrhage
- Primary source: https://clinicaltrials.gov/study/NCT05970224

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.